#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1247296	A	Cytotoxicity against human HeLa cells after 3 days by XTT assay	Homo sapiens	17		cell-based format	Scientific Literature
2.	ALA1247297	A	Cytotoxicity against human HeLa cells assessed as maximum non-cytotoxic concentration after 3 days by XTT assay	Homo sapiens	17		cell-based format	Scientific Literature
3.	ALA1247298	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells after 3 days by plaque reduction assay	Human rhinovirus 1B	17		organism-based format	Scientific Literature
4.	ALA1247299	A	Therapeutic index, ratio of TC50 for human HeLa cells to IC50 for HRV 1B		16		cell-based format	Scientific Literature
5.	ALA1247300	F	Antiviral activity against Human rhinovirus 14 infected in human HeLa cells after 3 days by plaque reduction assay	rhinovirus B14	16		organism-based format	Scientific Literature
6.	ALA1247302	A	Therapeutic index, ratio of TC50 for human HeLa cells to IC50 for HRV 14		9		cell-based format	Scientific Literature
7.	ALA1247303	A	Cytotoxicity against human Hep2 cells assessed as maximum non-cytotoxic concentration after 3 days by XTT assay	Homo sapiens	17		cell-based format	Scientific Literature
8.	ALA1247304	F	Antiviral activity against Human enterovirus 71 infected in human Hep2 cells after 2 days by plaque reduction assay	Enterovirus A71	17		organism-based format	Scientific Literature
9.	ALA1247305	F	Antiviral activity against Human enterovirus 71 infected in human Hep2 cells at maximum non-cytotoxic concentration after 3 days by plaque reduction assay	Enterovirus A71	17		organism-based format	Scientific Literature
10.	ALA1247306	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as virus inactivation at 20 uM at pH 5 after 1 hr by plaque reduction assay (Rvb = 2.86 x 10'7 PFU/ml)	Human rhinovirus 1B	1		organism-based format	Scientific Literature
11.	ALA1247307	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as virus stabilization at 20 uM at 56 degC after 1 hr by plaque reduction assay (Rvb = 3.5 x 10'7 PFU/ml)	Human rhinovirus 1B	1		organism-based format	Scientific Literature
12.	ALA1247308	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as inhibition of viral replication at 20 uM after 10 hrs by plaque reduction assay	Human rhinovirus 1B	1		organism-based format	Scientific Literature
13.	ALA1247309	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yeild at 20 uM treated immediately after virus infection measured after 10 hrs by plaque reduction assay	Human rhinovirus 1B	1		organism-based format	Scientific Literature
14.	ALA1247310	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yeild at 20 uM treated 30 mins after virus infection measured after 10 hrs by plaque reduction assay	Human rhinovirus 1B	1		organism-based format	Scientific Literature
15.	ALA1247311	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yeild at 20 uM treated 1 hr after virus infection measured after 10 hrs by plaque reduction assay	Human rhinovirus 1B	1		organism-based format	Scientific Literature
16.	ALA1247312	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yeild at 20 uM treated 2 to 4 hrs after virus infection measured after 10 hrs by plaque reduction assay	Human rhinovirus 1B	1		organism-based format	Scientific Literature
17.	ALA1247313	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yeild at 20 uM after 1 hr by plaque reduction assay	Human rhinovirus 1B	1		organism-based format	Scientific Literature
18.	ALA1247314	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yeild at 20 uM treated 1 hr before infection measured after 10 hrs by plaque reduction assay	Human rhinovirus 1B	1		organism-based format	Scientific Literature
19.	ALA1247315	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yeild at 20 uM treated immediately after virus infection measured 30 mins after washout by plaque reduction assay	Human rhinovirus 1B	1		organism-based format	Scientific Literature
20.	ALA1247316	F	Antiviral activity against Human rhinovirus 1B infected in human HeLa cells assessed as reduction of viral yeild at 20 uM treated immediately after virus infection measured >1 hr after washout by plaque reduction assay	Human rhinovirus 1B	1		organism-based format	Scientific Literature